Homo Sildenafil

CAS No. 642928-07-2

Homo Sildenafil( —— )

Catalog No. M24657 CAS No. 642928-07-2

Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 67 In Stock
2MG 33 In Stock
5MG 55 In Stock
10MG 88 In Stock
25MG 187 In Stock
50MG 275 In Stock
100MG 384 In Stock
200MG 541 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Homo Sildenafil
  • Note
    Research use only, not for human use.
  • Brief Description
    Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
  • Description
    Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    phosphodiesterase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    642928-07-2
  • Formula Weight
    488.6
  • Molecular Formula
    C23H32N6O4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jackie D Corbin, et al. Vardenafil: Structural Basis for Higher Potency Over Sildenafil in Inhibiting cGMP-specific phosphodiesterase-5 (PDE5). Neurochem Int. 2004 Nov;45(6):859-63.
molnova catalog
related products
  • MR-L2

    MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4).

  • Zomepirac Sodium

    Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.

  • Torbafylline

    Torbafylline, a xanthine derivative, is a phosphodiesterase (PDE) inhibitor that attenuates burn-induced protein hydrolysis in rat skeletal muscle through activation of the PDE4/cAMP/EPAC/PI3K/Akt pathway.